Mikhail A. Nikolaev

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses.

Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses.

Journal: Molecular biology reports

Published: May 21, 2026

Correction: Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Correction: Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Journal: Scientific reports

Published: October 14, 2025

The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice.

The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice.

Journal: Biochemistry. Biokhimiia

Published: August 31, 2025

Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1- and LRRK2-Associated Parkinson's Disease Patient-Derived Cells.

Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1- and LRRK2-Associated Parkinson's Disease Patient-Derived Cells.

Journal: Journal of neurochemistry

Published: December 17, 2024

Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.

Journal: Scientific reports

Published: August 16, 2024

Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.

Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.

Journal: Metabolites

Published: December 01, 2023

Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.

Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.

Journal: International journal of molecular sciences

Published: April 15, 2023

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 19, 2022

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.

Journal: Genes

Published: September 09, 2021

Increased α-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations.

Increased α-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 08, 2021

Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.

Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.

Journal: Parkinsonism & related disorders

Published: May 14, 2020

Plasma cytokine profile in synucleinophaties with dementia.

Plasma cytokine profile in synucleinophaties with dementia.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: February 20, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026